Influenza virus liposome vaccine intranasal (Berna Biotech/Sanofi Pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza virus liposome vaccine intranasal (Berna Biotech/Sanofi Pasteur)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi PasteurCrucell Holland Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi PasteurCrucell Holland Bv
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A